Exact Sciences Corporation ( EXAS) - Stock Earnings
Stock symbol EXAS is outdated, potentially delisted? Maybe it is available on other exchange?
EXAS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -1.2 million USD | 811.1 million USD |
| 2025Q3 | -19.6 million USD | 850.7 million USD |
| 2025Q4 | -86.0 million USD | 878.4 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
EXAS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -204.1 million USD | 2.5 billion USD |
| 2024 | -1.0 billion USD | 2.8 billion USD |
| 2025 | -207.9 million USD | 3.2 billion USD |
| 2026 Est. | — | — |
EXAS
Price: $104.91
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.09 USD
P/E Ratio: -94.95
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 953316
Ebitda: -23.0 millionMarket Capitalization: 19.8 billion